SCHEMBL6265164

SCHEMBL6265164

N[C@H](C=O)CC(=O)OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SLC15A1 P46059 2/20 0.55
▸ ALDH1A1 P00352 4/20 0.54
▸ MAPK1 P28482 1/20 0.54
▸ L3MBTL1 Q9Y468 1/20 0.54
▸ SLC1A3 P43003 2/20 0.47
▸ SLC1A2 P43004 2/20 0.47
▸ SLC1A1 P43005 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ CYP1A2 P05177 2/20 0.47
▸ CYP2C9 P11712 2/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ HCAR2 Q8TDS4 1/20 0.46
▸ SLC6A2 P23975 1/20 0.46
▸ SLC6A3 Q01959 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ CDC25B P30305 1/20 0.46
▸ LMNA P02545 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16596492 1.00 SLC15A1 (0.55) SLC15A1ALDH1A1MAPK1L3MBTL1SLC1A3
SCHEMBL2860601 0.86 SLC15A1 (0.53) SLC15A1ALDH1A1MAPK1L3MBTL1SLC1A3
SCHEMBL17210678 0.84 ALDH1A1 (0.51) SLC15A1ALDH1A1MAPK1L3MBTL1SLC1A3
SCHEMBL30020515 0.82 SLC15A1 (0.52) SLC15A1ALDH1A1MAPK1L3MBTL1SLC1A3
Hydrochloric Acid SCHEMBL27518479 0.81 ALDH1A1 (0.59) SLC15A1ALDH1A1MAPK1L3MBTL1SLC1A3
Hydrochloric Acid SCHEMBL19511476 0.81 ALDH1A1 (0.59) SLC15A1ALDH1A1MAPK1L3MBTL1SLC1A3
SCHEMBL6546883 0.81 ALDH1A1 (0.59) SLC15A1ALDH1A1MAPK1L3MBTL1SLC1A3
SCHEMBL10047603 0.81 ALDH1A1 (0.54) SLC15A1ALDH1A1MAPK1L3MBTL1KMT2A
SCHEMBL9792708 0.81 ALDH1A1 (0.54) SLC15A1ALDH1A1MAPK1L3MBTL1KMT2A
SCHEMBL17483756 0.81 ALDH1A1 (0.54) SLC15A1ALDH1A1MAPK1L3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1529030-A2 DERIVATIVES OF GLYCINERGIC R(+)-2-AMINO-3-HYDROXYPROPANOIC ACID Prestwick Pharmaceuticals, Inc. (US) 2005-05-11 — — EP claimed
WO-2004016580-A2 DERIVATIVES OF GLYCINERGIC R(+)-2-AMINO-3-HYDROXYPROPANOIC ACID PRESTWICK PHARMACEUTICALS, INC. (US) 2004-02-26 — — WO claimed
US-20120202243-A1 IN Vivo Incorporation of Unnatural Amino Acids THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-08-09 — — US disclosed
US-8173392-B2 In vivo incorporation of unnatural amino acids THE SCRIPPS RESEARCH INSTITUTE (US) 2012-05-08 — — US disclosed
US-8012739-B2 Methods and compositions for the production of orthogonal tRNA-aminoacyl-tRNA synthetase pairs THE SCRIPPS RESEARCH INSTITUTE (US) 2011-09-06 — — US disclosed
US-20090227002-A1 Methods and compositions for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs THE SCRIPPS RESEARCH INSTITUTE and THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2009-09-10 — — US disclosed
US-20090068717-A1 In vivo incorporation of unnatural amino acids THE SCRIPPS RESEARCH INSTITUTE (US) 2009-03-12 — — US disclosed
EP-1529030-A2 DERIVATIVES OF GLYCINERGIC R(+)-2-AMINO-3-HYDROXYPROPANOIC ACID Prestwick Pharmaceuticals, Inc. (US) 2005-05-11 — — EP disclosed
WO-2004016580-A2 DERIVATIVES OF GLYCINERGIC R(+)-2-AMINO-3-HYDROXYPROPANOIC ACID PRESTWICK PHARMACEUTICALS, INC. (US) 2004-02-26 — — WO disclosed
Send feedback